• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于将蛋白质连接到羟基磷灰石和骨表面的配体修饰氨基双膦酸盐。

Ligand-modified aminobisphosphonate for linking proteins to hydroxyapatite and bone surface.

作者信息

Ehrick Robin S, Capaccio Marcello, Puleo David A, Bachas Leonidas G

机构信息

Department of Chemistry, University of Kentucky, Lexington, Kentucky 40506-0055, USA.

出版信息

Bioconjug Chem. 2008 Jan;19(1):315-21. doi: 10.1021/bc700196q. Epub 2007 Nov 15.

DOI:10.1021/bc700196q
PMID:18001076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3247143/
Abstract

An increase in bone resorption is one of the main symptoms of osteoporosis, a disease that affects more and more individuals every day. Bisphosphonates are known to inhibit bone resorption and thus are being used as a treatment for osteoporosis. Aminobisphosphonates present a functionality that can be easily used for conjugation to other molecules, such as peptides, proteins, and ligands for protein recognition. In this study, an aminobisphosphonate conjugated with biotin was used as a model linker for protein attachment to bone. With this system, the interaction of biotinylated aminobisphosphonate with hydroxyapatite, a major mineral component of bone, was investigated. Quantification of the binding of aminobisphosphonate to hydroxyapatite was performed using a fluorescently labeled antibody for biotin. Additionally, the interaction of the biotinylated aminobisphosphonate with multiple treatments of cortical bone from the midshaft of a cow femur was studied. It was demonstrated that modified aminobisphosphonate reagents can bind hydroxyapatite and bone at high levels, while the biotin functionality is free to be recognized by the fluorescently labeled antibiotin antibody, suggesting that modified aminobisphosphonates could be used to link other peptides or proteins to the bone surface.

摘要

骨吸收增加是骨质疏松症的主要症状之一,这种疾病每天影响着越来越多的人。已知双膦酸盐可抑制骨吸收,因此被用作治疗骨质疏松症的药物。氨基双膦酸盐具有一种功能,可轻松用于与其他分子共轭,如肽、蛋白质以及用于蛋白质识别的配体。在本研究中,一种与生物素共轭的氨基双膦酸盐被用作蛋白质附着于骨的模型连接体。利用该系统,研究了生物素化氨基双膦酸盐与骨的主要矿物质成分羟基磷灰石之间的相互作用。使用针对生物素的荧光标记抗体对氨基双膦酸盐与羟基磷灰石的结合进行定量。此外,还研究了生物素化氨基双膦酸盐与来自奶牛股骨中段的皮质骨多次处理后的相互作用。结果表明,修饰后的氨基双膦酸盐试剂可高水平结合羟基磷灰石和骨,而生物素功能可被荧光标记的抗生物素抗体自由识别,这表明修饰后的氨基双膦酸盐可用于将其他肽或蛋白质连接到骨表面。

相似文献

1
Ligand-modified aminobisphosphonate for linking proteins to hydroxyapatite and bone surface.用于将蛋白质连接到羟基磷灰石和骨表面的配体修饰氨基双膦酸盐。
Bioconjug Chem. 2008 Jan;19(1):315-21. doi: 10.1021/bc700196q. Epub 2007 Nov 15.
2
Evaluation of the interaction between hydroxyapatite and bisphosphonate by nonlinear capillary electrochromatography.采用非线性胶束电动毛细管色谱法评价羟磷灰石与双膦酸盐的相互作用。
J Sep Sci. 2017 May;40(9):2030-2036. doi: 10.1002/jssc.201700028. Epub 2017 Mar 27.
3
Bisphosphonate conjugation to proteins as a means to impart bone affinity.双膦酸盐与蛋白质结合作为赋予骨亲和力的一种手段。
Biotechnol Prog. 2000 Mar-Apr;16(2):258-67. doi: 10.1021/bp990154m.
4
A comparison of the binding of biotin and biotinylated macromolecular ligands to an anti-biotin monoclonal antibody and to streptavidin.
J Immunol Methods. 1993 Oct 15;165(2):177-82. doi: 10.1016/0022-1759(93)90343-6.
5
Biotinylation of silicon-doped hydroxyapatite: a new approach to protein fixation for bone tissue regeneration.硅掺杂羟基磷灰石的生物素化:一种用于骨组织再生的蛋白质固定的新方法。
Acta Biomater. 2010 Mar;6(3):743-9. doi: 10.1016/j.actbio.2009.09.004. Epub 2009 Sep 12.
6
Interactions between Clinically Used Bisphosphonates and Bone Mineral: from Coordination Chemistry to Biomedical Applications and Beyond.临床应用双膦酸盐与骨矿物质的相互作用:从配位化学到生物医学应用及其他领域。
ChemMedChem. 2018 Feb 20;13(4):289-302. doi: 10.1002/cmdc.201700769. Epub 2018 Jan 30.
7
A DOTA based bisphosphonate with an albumin binding moiety for delayed body clearance for bone targeting.一种基于DOTA的双膦酸盐,带有白蛋白结合部分,用于延迟身体清除以实现骨靶向。
Nucl Med Biol. 2016 Nov;43(11):670-678. doi: 10.1016/j.nucmedbio.2016.07.009. Epub 2016 Aug 1.
8
Targeting systemically administered proteins to bone by bisphosphonate conjugation.通过双膦酸盐偶联将全身给药的蛋白质靶向至骨骼。
Biotechnol Prog. 2002 May-Jun;18(3):604-11. doi: 10.1021/bp0200447.
9
Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.双膦酸盐对骨骼作用的新见解:与羟基磷灰石相互作用的差异
Bone. 2006 May;38(5):617-27. doi: 10.1016/j.bone.2005.05.003. Epub 2005 Jul 20.
10
A novel intravascular drug delivery method using endothelial biotinylation and avidin-biotin binding.一种利用内皮生物素化和抗生物素蛋白-生物素结合的新型血管内药物递送方法。
Drug Deliv. 2001 Oct-Dec;8(4):215-22. doi: 10.1080/107175401317245895.

引用本文的文献

1
Synthesis of Amino--Bisphosphonate Derivatives and Their Application as Synthons for the Preparation of Biorelevant Compounds.氨基双膦酸酯衍生物的合成及其作为合成子在制备生物相关化合物中的应用。
Pharmaceuticals (Basel). 2025 Jul 18;18(7):1063. doi: 10.3390/ph18071063.
2
Enhanced affinity bifunctional bisphosphonates for targeted delivery of therapeutic agents to bone.增强亲和力双功能双膦酸盐用于将治疗剂靶向递送至骨骼。
Bioconjug Chem. 2011 Dec 21;22(12):2496-506. doi: 10.1021/bc2003132. Epub 2011 Dec 5.
3
Self-protecting bactericidal titanium alloy surface formed by covalent bonding of daptomycin bisphosphonates.

本文引用的文献

1
'Magic bullets' for bone diseases: progress in rational design of bone-seeking medicinal agents.治疗骨病的“神奇子弹”:靶向性骨药物合理设计的进展
Chem Soc Rev. 2007 Mar;36(3):507-31. doi: 10.1039/b512310k. Epub 2006 Sep 14.
2
Calcium plus vitamin D for postmenopausal women--bone appétit?钙加维生素D对绝经后女性——增强骨食欲?
N Engl J Med. 2006 Feb 16;354(7):750-2. doi: 10.1056/NEJMe068007.
3
Calcium plus vitamin D supplementation and the risk of fractures.补充钙加维生素D与骨折风险
通过二膦酸盐共价键合达托霉素形成的自保护杀菌钛合金表面。
Bioconjug Chem. 2010 Nov 17;21(11):1978-86. doi: 10.1021/bc100136e. Epub 2010 Oct 15.
N Engl J Med. 2006 Feb 16;354(7):669-83. doi: 10.1056/NEJMoa055218.
4
Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.双膦酸盐对骨骼作用的新见解:与羟基磷灰石相互作用的差异
Bone. 2006 May;38(5):617-27. doi: 10.1016/j.bone.2005.05.003. Epub 2005 Jul 20.
5
Mechanism of action of bisphosphonates.双膦酸盐的作用机制。
Curr Osteoporos Rep. 2003 Sep;1(2):45-52. doi: 10.1007/s11914-003-0008-5.
6
Targeting of therapeutic agents to bone to treat metastatic cancer.将治疗药物靶向作用于骨骼以治疗转移性癌症。
Adv Drug Deliv Rev. 2005 May 25;57(7):995-1010. doi: 10.1016/j.addr.2004.12.014. Epub 2005 Apr 13.
7
Toward new horizons: the future of bisphosphonate therapy.迈向新视野:双膦酸盐治疗的未来。
Oncologist. 2004;9 Suppl 4:38-47. doi: 10.1634/theoncologist.9-90004-38.
8
A di(bisphosphonic acid) for protein coupling and targeting to bone.一种用于蛋白质偶联并靶向骨骼的双膦酸。
J Pharm Sci. 2004 Nov;93(11):2788-99. doi: 10.1002/jps.20186.
9
Imparting bone mineral affinity to osteogenic proteins through heparin-bisphosphonate conjugates.通过肝素-双膦酸盐共轭物赋予成骨蛋白骨矿物质亲和力。
J Control Release. 2004 Aug 11;98(2):255-68. doi: 10.1016/j.jconrel.2004.05.001.
10
Imparting bone affinity to glycoproteins through the conjugation of bisphosphonates.通过双膦酸盐的共轭作用赋予糖蛋白骨亲和性。
Pharm Res. 2003 Jul;20(7):978-87. doi: 10.1023/a:1024445903306.